Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Title||Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer (EMERALD)|
|Recruitment||Active, not recruiting|
|Sponsors||Radius Pharmaceuticals, Inc.|
|Age Groups:||adult | senior|
|Covered Countries||USA | ITA | GBR | FRA | ESP | CAN | BEL | AUT | AUS|